Literature DB >> 17704987

St. John's wort: role of active compounds for its mechanism of action and efficacy.

Veronika Butterweck1, Mathias Schmidt.   

Abstract

St. John's wort (Hypericum perforatum L., SJW) contains numerous compounds with documented biological activity. Constituents that have stimulated the most interest include the naphthodianthrones hypericin and pseudohypericin, a broad range of flavonoids, and the phloroglucinols hyperforin and adhyperforin. According to the actual state of scientific knowledge the total extract has to be considered as the active substance. Although there are some open questions, the bulk of data suggests that several groups of active compounds are contributing to the antidepressant efficacy of the plant extract.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17704987     DOI: 10.1007/s10354-007-0440-8

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  53 in total

Review 1.  Hypericum perforatum (St John's Wort): a non-selective reuptake inhibitor? A review of the recent advances in its pharmacology.

Authors:  P J Nathan
Journal:  J Psychopharmacol       Date:  2001-03       Impact factor: 4.153

2.  In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract.

Authors:  J M Cott
Journal:  Pharmacopsychiatry       Date:  1997-09       Impact factor: 5.788

3.  Pharmacological activity of hyperforin acetate in rats.

Authors:  P Zanoli; M Rivasi; C Baraldi; M Baraldi
Journal:  Behav Pharmacol       Date:  2002-12       Impact factor: 2.293

Review 4.  St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature.

Authors:  J M Greeson; B Sanford; D A Monti
Journal:  Psychopharmacology (Berl)       Date:  2001-02       Impact factor: 4.530

5.  [Therapy of depressive states with hypericin].

Authors:  J Hoffmann; E D Kühl
Journal:  ZFA (Stuttgart)       Date:  1979-04-30

6.  Evaluation of synaptosomal uptake inhibition of most relevant constituents of St. John's wort.

Authors:  M Wonnemann; A Singer; B Siebert; W E Müller
Journal:  Pharmacopsychiatry       Date:  2001-07       Impact factor: 5.788

7.  Extracts and constituents of Hypericum perforatum inhibit the binding of various ligands to recombinant receptors expressed with the Semliki Forest virus system.

Authors:  U Simmen; W Burkard; K Berger; W Schaffner; K Lundstrom
Journal:  J Recept Signal Transduct Res       Date:  1999 Jan-Jul       Impact factor: 2.092

8.  Rutin is essential for the antidepressant activity of Hypericum perforatum extracts in the forced swimming test.

Authors:  Michael Nöldner; Karl Schötz
Journal:  Planta Med       Date:  2002-07       Impact factor: 3.352

Review 9.  Mechanism of action of St John's wort in depression : what is known?

Authors:  Veronika Butterweck
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 10.  Hyperforin in St. John's wort drug interactions.

Authors:  Rajanikanth Madabushi; Bruno Frank; Bernd Drewelow; Hartmut Derendorf; Veronika Butterweck
Journal:  Eur J Clin Pharmacol       Date:  2006-02-14       Impact factor: 2.953

View more
  32 in total

Review 1.  Drug interactions with herbal medicines.

Authors:  Shaojun Shi; Ulrich Klotz
Journal:  Clin Pharmacokinet       Date:  2012-02-01       Impact factor: 6.447

Review 2.  Ethnobotany as a pharmacological research tool and recent developments in CNS-active natural products from ethnobotanical sources.

Authors:  Will C McClatchey; Gail B Mahady; Bradley C Bennett; Laura Shiels; Valentina Savo
Journal:  Pharmacol Ther       Date:  2009-05-05       Impact factor: 12.310

Review 3.  The mechanisms of action of St. John's wort: an update.

Authors:  Mathias Schmidt; Veronika Butterweck
Journal:  Wien Med Wochenschr       Date:  2015-07-17

Review 4.  Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.

Authors:  Jerome Sarris; Erica McIntyre; David A Camfield
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

Review 5.  Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function.

Authors:  David O Kennedy; Emma L Wightman
Journal:  Adv Nutr       Date:  2011-01-10       Impact factor: 8.701

6.  Hyperforin is a modulator of inducible nitric oxide synthase and phagocytosis in microglia and macrophages.

Authors:  Birgit Kraus; Horst Wolff; Erich F Elstner; Jörg Heilmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-04-06       Impact factor: 3.000

7.  Hypericin prolongs action potential duration in hippocampal neurons by acting on K+ channels.

Authors:  Y Wang; X Shi; Z Qi
Journal:  Br J Pharmacol       Date:  2010-03-02       Impact factor: 8.739

8.  Identification of light-independent inhibition of human immunodeficiency virus-1 infection through bioguided fractionation of Hypericum perforatum.

Authors:  Wendy Maury; Jason P Price; Melinda A Brindley; ChoonSeok Oh; Jeffrey D Neighbors; David F Wiemer; Nickolas Wills; Susan Carpenter; Cathy Hauck; Patricia Murphy; Mark P Widrlechner; Kathleen Delate; Ganesh Kumar; George A Kraus; Ludmila Rizshsky; Basil Nikolau
Journal:  Virol J       Date:  2009-07-13       Impact factor: 4.099

9.  No clinically relevant CYP3A induction after St. John's wort with low hyperforin content in healthy volunteers.

Authors:  Silke C Mueller; Jolanta Majcher-Peszynska; Ralf G Mundkowski; Bernhard Uehleke; Sebastian Klammt; Hartwig Sievers; Romanus Lehnfeld; Bruno Frank; Kerstin Thurow; Guenther Kundt; Bernd Drewelow
Journal:  Eur J Clin Pharmacol       Date:  2008-09-03       Impact factor: 2.953

10.  Identification and biosynthesis of acylphloroglucinols in Hypericum gentianoides.

Authors:  Matthew C Crispin; Manhoi Hur; Taeseong Park; Young Hwan Kim; Eve Syrkin Wurtele
Journal:  Physiol Plant       Date:  2013-05-24       Impact factor: 4.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.